NCT04892524

Brief Summary

This is a study to determine how a virtual model for the management of lung nodules compares to a face-to-face clinic for patient satisfaction, quality of life and cost.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2021

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

1.1 years

First QC Date

May 7, 2021

Last Update Submit

September 19, 2022

Conditions

Keywords

Pulmonary noduleLung noduleSolitary pulmonary noduleLung cancerVirtual clinic

Outcome Measures

Primary Outcomes (1)

  • Cost

    Economic cost to participants and our health service, measured by an investigator-derived questionnaire asking participants to describe time spent engaging in the their health care and any direct costs associated with visits. Economical modelling will also be applied to determine the staffing and resource costs associated with provision of care to participants in each arm.

    6 months

Secondary Outcomes (2)

  • Participant satisfaction

    6 months

  • Anxiety

    6 months

Study Arms (2)

Virtual multidisciplinary review

EXPERIMENTAL

Participants in this arm will be reviewed in a virtual clinic by a multidisciplinary team

Other: Virtual multidisciplinary review

Face-to-face review

NO INTERVENTION

Participants in this group will be reviewed in a face-to-face clinic

Interventions

The virtual multidisciplinary review involves participants being reviewed by a multi-disciplinary team of specialist doctors, nurses and radiologists in a virtual environment. The team will analyse radiologic scans and make a recommendations for any follow-up scans, procedures or appointments that may be required

Virtual multidisciplinary review

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80 years
  • At least 1 IPN identified on CT imaging measuring 4-30 mm in maximal diameter
  • CT slice thickness of 3 mm or less

You may not qualify if:

  • Previous diagnosis of lung cancer
  • History of haemoptysis
  • Unexplained weight loss \> 7 kg in the preceding 12 months
  • Past history of malignancy within 5 years (excluding non-melanoma skin cancer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Flinders Medical Centre

Bedford Park, South Australia, 5042, Australia

Location

MeSH Terms

Conditions

Solitary Pulmonary NoduleMultiple Pulmonary NodulesLung Neoplasms

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Study Officials

  • Anand Rose

    Southern Adelaide Local Health Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2021

First Posted

May 19, 2021

Study Start

April 19, 2021

Primary Completion

May 30, 2022

Study Completion

October 1, 2023

Last Updated

September 21, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations